Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 213

1.

How can optimization of medical treatment avoid unnecessary implantable cardioverter-defibrillator implantations in patients with idiopathic dilated cardiomyopathy presenting with "SCD-HeFT criteria?".

Zecchin M, Merlo M, Pivetta A, Barbati G, Lutman C, Gregori D, Serdoz LV, Bardari S, Magnani S, Di Lenarda A, Proclemer A, Sinagra G.

Am J Cardiol. 2012 Mar 1;109(5):729-35. doi: 10.1016/j.amjcard.2011.10.033. Epub 2011 Dec 15.

PMID:
22176998
2.

Implantable cardioverter defibrillators. Prophylactic use: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2005;5(14):1-74. Epub 2005 Sep 1.

3.
4.

The role of implantable cardioverter defibrillator for primary vs secondary prevention of sudden death in patients with idiopathic dilated cardiomyopathy.

Zecchin M, Di Lenarda A, Proclemer A, Faganello G, Facchin D, Petz E, Sinagra G.

Europace. 2004 Sep;6(5):400-6. Erratum in: Europace. 2005 Jan;7(1):91.

7.

Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.

Lelakowski J, Piekarz J, Rydlewska A, Majewski J, Senderek T, Ząbek A, Małecka B.

Kardiol Pol. 2012;70(11):1099-110.

8.

Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy.

Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, Calkins H, Hoch D, Goldberger J, Shalaby A, Sanders WE, Schaechter A, Levine JH; Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators.

N Engl J Med. 2004 May 20;350(21):2151-8.

9.

Incidence of left ventricular function improvement after primary prevention ICD implantation for non-ischaemic dilated cardiomyopathy: a multicentre experience.

Verma A, Wulffhart Z, Lakkireddy D, Khaykin Y, Kaplan A, Sarak B, Biria M, Pillarisetti J, Bhat P, Di Biase L, Constantini O, Quan K, Natale A.

Heart. 2010 Apr;96(7):510-5. doi: 10.1136/hrt.2009.178061. Epub 2009 Nov 1.

PMID:
19884110
10.

[14-year experience with implantable cardioverter/defibrillators: determination of prognosis and discharge behavior].

Vester EG, Dees H, Dobran I, Hennersdorf M, Perings C, Heydthausen M, Winter J, Strauer BE.

Z Kardiol. 2000;89 Suppl 3:194-205. German.

PMID:
10810803
11.

New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II.

Klein H, Auricchio A, Reek S, Geller C.

Am J Cardiol. 1999 Mar 11;83(5B):91D-97D. Review.

PMID:
10089848
12.

Improving survival rates of patients with idiopathic dilated cardiomyopathy in Tuscany over 3 decades: impact of evidence-based management.

Castelli G, Fornaro A, Ciaccheri M, Dolara A, Troiani V, Tomberli B, Olivotto I, Gensini GF.

Circ Heart Fail. 2013 Sep 1;6(5):913-21. doi: 10.1161/CIRCHEARTFAILURE.112.000120. Epub 2013 Jul 25.

13.

Determinants of mortality in patients undergoing cardiac resynchronization therapy: baseline clinical, echocardiographic, and angioscintigraphic evaluation prior to resynchronization.

de Sisti A, Toussaint JF, Lavergne T, Ollitrault J, Abergel E, Paziaud O, Ait Said M, Sader R, LE Heuzey JY, Guize L.

Pacing Clin Electrophysiol. 2005 Dec;28(12):1260-70.

PMID:
16403157
14.

Primary prevention of sudden cardiac death in a nonischemic dilated cardiomyopathy population: reappraisal of the role of programmed ventricular stimulation.

Gatzoulis KA, Vouliotis AI, Tsiachris D, Salourou M, Archontakis S, Dilaveris P, Gialernios T, Arsenos P, Karystinos G, Sideris S, Kallikazaros I, Stefanadis C.

Circ Arrhythm Electrophysiol. 2013 Jun;6(3):504-12. doi: 10.1161/CIRCEP.113.000216. Epub 2013 Apr 15.

15.

A Latin American registry of implantable cardioverter defibrillators: the ICD-LABOR study.

Dubner S, Valero E, Pesce R, Zuelgaray JG, Mateos JC, Filho SG, Reyes W, Garillo R.

Ann Noninvasive Electrocardiol. 2005 Oct;10(4):420-8.

PMID:
16255752
16.

Mid-term results of heart transplantation, cardiomyoplasty, and medical treatment of refractory heart failure caused by idiopathic dilated cardiomyopathy.

Bocchi EA, Bellotti G, Moreira LF, Bacal F, de Moraes AV, Fiorelli A, Mansur A, Stolf N, Jatene A, Pileggi F.

J Heart Lung Transplant. 1996 Jul;15(7):736-45.

PMID:
8820791
17.

Sudden cardiac death in dilated cardiomyopathy -- therapeutic options.

Grimm W, Maisch B.

Herz. 2002 Dec;27(8):750-9. Review.

PMID:
12574892
18.

Metoprolol in dilated cardiomyopathy: is it possible to identify factors predictive of improvement? The Heart Muscle Disease Study Group.

DiLenarda A, Gregori D, Sinagra G, Lardieri G, Perkan A, Pinamonti B, Salvatore L, Secoli G, Zecchin M, Camerini F.

J Card Fail. 1996 Jun;2(2):87-102.

PMID:
8798110
19.

Long-term follow-up of patients with indication for a implantable defibrillator for primary prevention of death.

Hadid C, Avellana P, Di Toro D, Gomez CF, Visser M, Prieto N.

Arq Bras Cardiol. 2008 May;90(5):311-5. English, Portuguese.

20.

Prophylactic implantable defibrillators in dilated cardiomyopathy.

Grimm W.

Herz. 2012 Dec;37(8):859-66. doi: 10.1007/s00059-012-3687-9.

PMID:
23052902
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk